F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
Based on interview and record review the facility failed to develop a plan of care for administering,
assessing and monitoring the use of antipsychotic medications administered to 2 of 4 residents (R21 and
R23) reviewed for Care Plans in a sample of 25.
Findings included:
1. According to R21's face sheet R21 was admitted to this facility on 11/21/2021 with the diagnosis of
Anxiety, Depression, Insomnia and Dementia among other non-psychiatric diagnosis
According to R21's Physician Order Sheet for December 2022, (12/1/2022 through 12/31/2022), R21 was
prescribed a second generation antipsychotic medication on 4/13/2022 called Seroquel 25mg by mouth at
bedtime for depression. On 7/13/2022 R21 was prescribed another second generation antipsychotic
medication called Geodon 20mg by mouth every day for increased agitation and anxiety with increased
behavioral problems. On 12/14/2022 at 1:30pm, V2 (Director of Nursing/DON) verified R21 has taken both
medications since they were prescribed.
A review of R21's care plan with a start date of 11/21/2021 showed R21's care plan lacked having any
information concerning R21's psychotropic medication, including when and how the medication is to be
administered. R21's care plan lacked a plan of care for how staff should monitor/track R21's behaviors that
the psychotropic medications are to treat.
2. According to R23's face sheet, R23 was admitted to this facility on 3/16/2021 with the diagnosis of H/O
(History of) Dementia and Behavioral/Psychiatric symptoms of Dementia among other non-psychiatric
diagnosis.
According to R23's Physician Order Sheet for December 2022 (12/1/2022 through 12/31/2022) R23 was
prescribed a second generation antipsychotic medication on 3/16/2021 called Seroquel 125mg by mouth,
every day related to Anxiety. On 6/23/2022 R23 was prescribed an additional second generation
antipsychotic medication called Geodon 20mg by mouth at 5:00pm related to Dementia and Agitation. On
12/14/2022 at 1:30pm, V2 (Director of Nursing/DON) verified R21 has taken both medications since they
were prescribed.
A review of R23's care plan with a start date of 3/16/2021 showed R23's care plan lacked having any
information concerning R23's psychotropic medication, including when and how the medication is to be
administered. R23's care plan also lacked a plan of care for how staff should monitor/track R23's behaviors
that the psychotropic medications are to treat.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
146070
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146070
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/15/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Twin Willows Nursing Center
1600 North Broadway
Salem, IL 62881
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
On 12/15/2022 at 11:30am, V2 (Director of Nursing/DON) said a psychotropic medications should have
been addressed in R21 and R23's care plans but it had been missed and not included.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146070
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146070
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/15/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Twin Willows Nursing Center
1600 North Broadway
Salem, IL 62881
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on interview and record review the facility failed 1.) to ensure psychotropic medications were used
for an appropriate indicated use, 2.) to track target psychiatric symptoms being treated and 3.) to ensure
non-duplicate drug therapy is administered for 2 of 4 residents (R21, R23) reviewed for unnecessary
psychotropic medication in a sample of 25.
Findings Include:
1. According to R21's face sheet R21 was admitted to this facility on 11/21/2021 with the diagnosis of
Anxiety, Depression, Insomnia and Dementia among other non-psychiatric diagnosis
According to R21's Physician Order Sheet for December 2022, (12/1/2022 through 12/31/2022), R21 was
prescribed a second generation antipsychotic medication on 4/13/2022 called Seroquel 25mg by mouth at
bedtime for depression. On 7/13/2022 R21 was prescribed another second generation antipsychotic
medication called Geodon 20mg by mouth every day for increased agitation and anxiety with increased
behavioral problems. On 12/14/2022 at 1:30pm, V2 (Director of Nursing/DON) verified R21 has taken both
medications since they were prescribed.
2. According to R23's face sheet, R23 was admitted to this facility on 3/16/2021 with the diagnosis of H/O
(History of) Dementia and Behavioral/Psychiatric symptoms of Dementia among other non psychiatric
diagnosis.
According to R23's Physician Order Sheet for December 2022 (12/1/2022 through 12/31/2022) R23 was
prescribed a second generation antipsychotic medication on 3/16/2021 called Seroquel 125mg by mouth,
every day related to Anxiety. On 6/23/2022 R23 was prescribed an additional second generation
antipsychotic medication called Geodon 20mg by mouth at 5:00pm related to Dementia and Agitation. On
12/14/2022 at 1:30pm, V2 (Director of Nursing/DON) verified R21 has taken both medications since they
were prescribed.
On 12/15/2022 at 11:30am, V10 (Pharmacist) said he reviews each resident's medication regimen every
month and makes recommendations accordingly. V10 said he noticed R23 and R21 both are being
prescribed two medications in the same drug classification and this is called duplicate medications
regimen. V10 said taking duplicate second generation psychotropic medications doesn't make the
medications work better, can have serious cardiac side effects and is actually against federal and state long
term care regulations. V10 said he has notified both R23 and R21's doctor and the facility of R21 and R23
not having an appropriate diagnosis for being prescribed psychotropic medications but it has not been
addressed as of today. A facility document located in R23's medical record and dated 6/28/2021 shows V10
had sent written notification to R23's doctor and the nursing home concerning R23 being on duplicate
antipsychotic medication and the diagnosis of Dementia, Agitation and Anxiety were not appropriate
indications for the use of psychotropic medications. V10 said he also sent written notification on 4/25/2021
to R21's physician and the facility concerning R21 being on duplicate drugs and them being used for the
inappropriate diagnosis of Agitation/Anxiety with increased behavioral problems and Depression. On
12/14/2022 at 1:30pm, V2 (Director of Nursing) said she could not locate any of V10's recommendations for
R21. V2 agreed that V10 had performed monthly reviews of R21's medications, however the facility did not
manage to keep track of the documents.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146070
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146070
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/15/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Twin Willows Nursing Center
1600 North Broadway
Salem, IL 62881
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
On 12/14/2022 at 1:30pm, V2 (DON) said she knows the facility's nursing staff is supposed to be tracking
the symptoms in for which the resident is prescribed psychotropic medications but they have not been
doing this and she freely admits it. V2 said she will immediately begin re-educating the staff on this subject
and get the practice back in tract. V2 said she was not aware of any residents being on duplicate drug
therapies, including antipsychotic medications. V2 said they will do better with the psychotropic medication
symptom tracking/monitoring in the future.
On 12/14/2022 at 1:30pm, V2 agreed the nursing staff had not followed the facility's Psychotropic
Medication policy but should have.
A facility policy titled Policy for Administration of Psychotropic Medications (not dated) under the section
titled Procedure documents the following Follow the requirements as stated in the Illinois Department of
Public Health Administrative Code for assessments, administration, monitoring and dose reduction
recommendations for administering, monitoring, reduction and/or discontinuance an psychotropic drug;
considered for behavior modification. Under the section titled Documentation it documents the following
Document in the resident's medical record the assessments, administration, behavior tracking and
interventions and outcome of the medication as directed by the Illinois Department of Public Health
Administration code.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146070
If continuation sheet
Page 4 of 4